Can-Fite BioPharma CANF
NYSE CANF
$1.85 -0.04 (-2.39%)
As of: Oct 22, 2026 · 3:31 PM EDT

Can-Fite BioPharma (CANF) Cash from Operations (2012 - 2013)

Updated

Can-Fite BioPharma's Cash from Operations came in at -$8.95 million for FY2025, compared with -$7.64 million in FY2024.

Analysis

Can-Fite BioPharma (CANF) Cash from Operations (2012 - 2013) Analysis & Trends

Going back to FY2015, Can-Fite BioPharma's Cash from Operations data covers 11 years.

  • The FY2025 figure represents the lowest annual Cash from Operations since FY2022.
  • Per Business Quant, earlier years put Cash from Operations at -$7.64 million in FY2024, -$8.44 million in FY2023, -$10.8 million in FY2022 and -$9.86 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 7.72 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 3.44 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.87 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.57 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 835.00 Mn
10 Can-Fite BioPharma 1.52 Mn -18.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -3.20 Mn
Sep 30, 2013 -1.39 Mn
Jun 30, 2013 -2.51 Mn
Dec 31, 2012 -2.76 Mn
Sep 30, 2012 -381,325.47
Jun 30, 2012 -1.44 Mn
API Access

Can-Fite BioPharma Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=CANF&period=max&api_key=YOUR_API_KEY